Victory Capital Management’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.59M | Buy |
22,460
+819
| +4% | +$44.2K | ﹤0.01% | 1705 |
|
|
2026
Q1 | $1.13M | Sell |
21,641
-1,592
| -7% | -$95.6K | ﹤0.01% | 1793 |
|
|
2025
Q4 | $1.37M | Buy |
23,233
+1,533
| +7% | +$93.1K | ﹤0.01% | 1686 |
|
|
2025
Q3 | $1.21M | Sell |
21,700
-1,762
| -8% | -$94.4K | ﹤0.01% | 1749 |
|
|
2025
Q2 | $1.21M | Sell |
23,462
-395
| -2% | -$19.8K | ﹤0.01% | 1759 |
|
|
2025
Q1 | $1.4M | Sell |
23,857
-17,846
| -43% | -$1.21M | ﹤0.01% | 1648 |
|
|
2024
Q4 | $3M | Sell |
41,703
-891
| -2% | -$65.4K | ﹤0.01% | 1391 |
|
|
2024
Q3 | $3.4M | Sell |
42,594
-3,022
| -7% | -$227K | ﹤0.01% | 1351 |
|
|
2024
Q2 | $3.27M | Sell |
45,616
-1,363
| -3% | -$100K | ﹤0.01% | 1320 |
|
|
2024
Q1 | $3.31M | Sell |
46,979
-1,957
| -4% | -$140K | ﹤0.01% | 1332 |
|
|
2023
Q4 | $3.78M | Buy |
48,936
+17,576
| +56% | +$1.16M | ﹤0.01% | 1286 |
|
|
2023
Q3 | $2.13M | Sell |
31,360
-7,783
| -20% | -$615K | ﹤0.01% | 1371 |
|
|
2023
Q2 | $3.2M | Buy |
39,143
+1,205
| +3% | +$96.9K | ﹤0.01% | 1281 |
|
|
2023
Q1 | $2.81M | Sell |
37,938
-41,052
| -52% | -$3.16M | ﹤0.01% | 1323 |
|
|
2022
Q4 | $6.55M | Sell |
78,990
-2,926
| -4% | -$232K | 0.01% | 1144 |
|
|
2022
Q3 | $5.82M | Sell |
81,916
-11,868
| -13% | -$1.03M | 0.01% | 1204 |
|
|
2022
Q2 | $8.13M | Buy |
93,784
+8,312
| +10% | +$779K | 0.01% | 1129 |
|
|
2022
Q1 | $8.11M | Sell |
85,472
-12,328
| -13% | -$1.27M | 0.01% | 1175 |
|
|
2021
Q4 | $12.6M | Sell |
97,800
-1,004
| -1% | -$123K | 0.01% | 1060 |
|
|
2021
Q3 | $12M | Sell |
98,804
-12,400
| -11% | -$1.51M | 0.01% | 1046 |
|
|
2021
Q2 | $12.5M | Buy |
111,204
+2,608
| +2% | +$275K | 0.01% | 1058 |
|
|
2021
Q1 | $10.4M | Buy |
108,596
+14,776
| +16% | +$1.35M | 0.01% | 1133 |
|
|
2020
Q4 | $7.45M | Buy |
93,820
+740
| +0.8% | +$53.6K | 0.01% | 1148 |
|
|
2020
Q3 | $5.76M | Buy |
93,080
+5,764
| +7% | +$375K | 0.01% | 1167 |
|
|
2020
Q2 | $5.76M | Buy |
87,316
+7,416
| +9% | +$444K | 0.01% | 1133 |
|
|
2020
Q1 | $3.79M | Sell |
79,900
-20,752
| -21% | -$1.04M | 0.01% | 1157 |
|
|
2019
Q4 | $5.52M | Buy |
100,652
+8,488
| +9% | +$445K | 0.01% | 1156 |
|
|
2019
Q3 | $4.51M | Buy |
92,164
+35,212
| +62% | +$1.77M | 0.01% | 1191 |
|
|
2019
Q2 | $2.97M | Sell |
56,952
-3,368
| -6% | -$170K | 0.01% | 1039 |
|
|
2019
Q1 | $2.99M | Sell |
60,320
-19,136
| -24% | -$861K | 0.01% | 986 |
|
|
2018
Q4 | $2.88M | Sell |
79,456
-292
| -0.4% | -$12.2K | 0.01% | 946 |
|
|
2018
Q3 | $4.07M | Sell |
79,748
-31,920
| -29% | -$1.41M | 0.01% | 925 |
|
|
2018
Q2 | $4.13M | Buy |
111,668
+13,128
| +13% | +$501K | 0.01% | 891 |
|
|
2018
Q1 | $3.72M | Buy |
+98,540
| New | +$3.48M | 0.01% | 885 |
|
|
2013
Q4 | – | Sell |
-448
| Closed | -$8K | – | 1094 |
|
|
2013
Q3 | $8K | Buy |
+448
| New | +$8.5K | ﹤0.01% | 1066 |
|
Other funds holding TECH
HI
Victory Capital Management's TECH Position: Q2 2026 in Review
Victory Capital Management increased its Bio-Techne (TECH) stake by 3.8% in Q2 2026, buying an estimated $44.2K and bringing the position to 22,460 shares worth $1.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1705.
Victory Capital Management first reported a position in TECH in Q3 2013 and has held it in 35 quarters since. The position peaked at $12.6M in Q4 2021. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.
- Victory Capital Management held 22,460 shares of Bio-Techne worth $1.59M as of Q2 2026.
- Victory Capital Management bought 819 Bio-Techne shares in Q2 2026, an estimated $44.2K.
- Bio-Techne made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #1705 holding.
- Victory Capital Management first reported a position in Bio-Techne in Q3 2013 and has held it in 35 quarters since.
- Victory Capital Management's Bio-Techne position peaked at $12.6M in Q4 2021.
- 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.
Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.